Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genentech receives fast track product designation for Herceptin

April 2, 1998

Dendreon's dendritic cell-based immunotherapy reported at AACR

March 30, 1998

Novel fusion protein with potent activity in colon cancer models reported at AACR

March 30, 1998

U.S. patent issues for Immunex's soluble CD40 ligand

March 30, 1998

Canadian notice of patent allowance for Imutec's Virulizin

March 30, 1998

Promising preliminary results obtained with Melacine/Intron A combination in stage IV melanoma

March 27, 1998

Cytogen halts autologous lymphocyte therapy program

March 27, 1998

Coulter completes patient enrollment in Bexxar phase III trial

March 25, 1998

Phase II ImmTher trial begins in pediatric cancer patients

March 19, 1998

Cel-Sci expands North American clinical trial for Multikine

March 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...